day 2 - immunology of joint disease Flashcards

1
Q

define rheumatoid arthritis

A

Definition: Symmetrical autoimmune polyarthritis commonly affecting the peripheral joints. It is a severe inflammatory disorder which can affect men and women of any age

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

epitome of RA

A

Epidemiology:
Common disease (1-2% of population)
M:F ratio 1:3
Peak incidence: young adults and premenopausal women

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

RA diagnosis

A

Diagnosis is clinical: insidious, symmetrical arthritis, with painful, swollen joints.
A new diagnostic test for anti-cyclic citrullinated protein antibodies has been shown to be specific for rheumatoid arthritis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

path of RA

A

Pathology:
Main target is the synovium: inflammation, vasculitis, oedema, villous hypertrophy, chronic inflammation, infiltration by lymphocytes and macrophages, proliferation of synovial cells and erosion of articular cartilage.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

evidence of the role of the immune system in RA?

A

Evidence for role of the immune system in the disease:
High % have particular HLA type (DR4).
Associated with the presence in the blood of high titre of rheumatoid factor, an auto- antibody (usually IgM) reactive with altered autologous immunoglobulin (also anti- ribonucleoprotein and anti-perinuclear factor).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

multi systems affected by RA

A

Multi-system disorder:
Marked by a variable course with exacerbations and remissions
• chronic inflammatory granulomatous lesions (rheumatoid nodules) at many sites,
especially subcutaneous.
• vasculitis: including skin, eyes (scleritis, keratoconjunctivitis) neuropathies.
• pulmonary disease: fibrosing alveolitis, effusions and pleuritis, Caplan’s syndrome.
• Sjogren’s syndrome.
• amyloidosis.
• haematological abnormalities: anaemia, lymphadenopathy, splenomegaly, hyperviscosity.
• local complications, e.g. tendon and nerve damage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what is • Sjogren’s syndrome.

A

Sjögren’s syndrome or Sjögren syndrome (pronounced /ˈʃoʊɡrɨn/ or /ˈʃʌrɡrɛn/[1] in English, the latter to approximate the Swedish pronounciation) is a chronic autoimmune disease in which the body’s white blood cells destroy the exocrine glands, specifically the salivary and lacrimal glands, that produce saliva and tears, respectively.[2] The immune-mediated attack on the salivary and lacrimal glands leads to the development of xerostomia (dry mouth) and keratoconjunctivitis sicca (dry eyes), which takes place in association with lymphocytic infiltration of the glands.[3] That inflammatory process eventually severely damages or destroys the glands.

Sjögren’s syndrome is usually classified by a clinician as either ‘primary’ or ‘secondary’. Primary Sjögren’s syndrome occurs by itself and secondary Sjögren’s syndrome occurs when another connective tissue disease is present

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

what is amyloidosis

A

Amyloidosis is a rare disease that results from accumulation of inappropriately folded proteins. These misfolded proteins are called amyloids. When proteins that are normally soluble in water, fold to become amyloids, they become insoluble and deposit in organs or tissues, disrupting normal function.[2][3] The type of protein that is misfolded and the organ or tissue in which the misfolded proteins are deposited determines the clinical manifestations of amyloidosis.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

what is felty’s syndrome?

A

Felty’s syndrome, also called Felty syndrome,[1] is characterized by the combination of rheumatoid arthritis, splenomegaly and neutropenia. The condition is more common in those aged 50-70 years, and is more prevalent in females than males and more in Caucasians than blacks. It is a deforming but inactive disease and seropositive for RF

Felty’s syndrome:
• Destructive arthritis.
• High frequency of extra-articular manifestations especially vasculitis.
• Strong family history and HLA DR4 association.
• Lymphadenopathy and splenomegaly.
• Leucopenia, often neutropenia with increased susceptibility to infection.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

role of T cells in RA

A

Role of T cells?
• Dense infiltrate of activated mature T cells (mainly CD4+ in synovium).
• Close association with particular MHC polymorphism HLA DR4.
• Therapy directed against T cells has been shown to be effective in treatment in some
cases.
• Most animal models are T cell dependent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

role of B cells in RA

A

Role of B cells and antibodies?
• Anti B cell therapy has proved successful.
• Some animal models are B cell dependent.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

role of cytokines in RA

A

Role of cytokines?
• Evidence from both animal models and human studies that immunoregulatory cytokines are important
• Role of tumour necrosis factor (TNF): was shown to be pivotal (but not exclusive) cytokine, acting directly in both pro- and anti-inflammatory networks, and indirectly via effect on interleukins (IL), especially IL-1 and IL-6.
• Exploited to generate biological therapeutics (e.g. anti-TNF, soluble TNF receptor) which have proved to be of therapeutic value.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Possible components in the immunopathogenesis of rheumatoid arthritis:

A

Possible components in the immunopathogenesis of rheumatoid arthritis:
• Immune complex mediated disease.
• Dysregulation of T cells and/or macrophages in the synovium with persistent
production of pro-inflammatory mediators (e.g. TNF).
• Abnormal antigen presentation in synovium.
• Excess production of free radicals and matrix metalloproteases in the synovium.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Adverse prognostic factors in rheumatoid arthritis:

A
  • High titre of serum rheumatoid factor.
  • Presenting feature of insidious onset, > 50 years of age, symmetrical arthritis. • Joint erosions on X ray.
  • Early appearance of nodules or vasculitis.
  • Persistent disease activity in the first year after diagnosis.
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

current treatments for RA

A

Current treatments:
• NSAIDS / Steroids.
• DMARD: methotrextrate, ciclosporin, gold, penicillamine, azathioprine.

• Anti TNFalpha/soluble receptor/IL-1. • Anti CD20 antibodies.
Potential future treatments:
• Anti BAFF.
• Anti angiogenesis treatments? • Gene therapy?

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

what is SLE

A

Systemic lupus erythematosus

Systemic disorder characterised by the presence of circulating auto-antibodies directed
against nuclear components:
• anti-DNA (ss or ds) (note different patterns of staining on nuclei of Hep2 cell line);
• anti-histone;
• anti-Ro, anti-La, anti-Sm;
• can also can have auto-antibodies against other components of the cell:
• anti-phospholipid (associated with thrombosis) – phospholipid associated proteins especially
beta 2 glycoprotein 1;
• anti-red cell (associated with haemolytic anaemia);
• rheumatoid factor;
• cell or organelle specific, e.g. mitochondria, smooth muscle cell.

17
Q

SLE epidemiology

A

Epidemiology:
• Female&raquo_space; male
• Drug - induced forms - similar disease?
• Auto-antibodies may be present, but no disease seen?
• Familial but not HLA-linked

18
Q

clinical manifestations of SLE

A

Principal clinical syndromes:
• Arthritis - low grade, no pannus, no erosions
• Erythema - butterfly rash, alopecia, photosensitivity
• Lymphadenopathy and splenomegaly
• Anaemia and leucopenia
• Myalgia
• Serositis - pleuritis, pericarditis
• Glomerulonephritis
• Pulmonary manifestations: fibrosing alveolitis
• Endocarditis (Libman - Sacks)
• Neurological manifestations - association with arteritis, thrombosis, anti-cardiolipin antibodies

19
Q

hypotheses of pathogen of SLE

A

Numerous hypotheses about pathogenesis: primary and perpetuating phases of disease are recognised:

  1. Immune complex mediated disease
  2. Association with primary classic complement deficiencies
  3. Infectious agent: viral
  4. Environmental agents: drugs, photosensitivity
  5. Genetic associations
  6. Defect in immunoregulation
20
Q

immunological investigations in RA and SLE

A

Rheumatoid factor:
RA = +ve in >70%; high titre
SLE = +ve in <10%
SLE = +ve, 70-80%

CRP
RA = increased
SLE = usually normal

C3 and C4 levels
RA = normal or increased
SLE = normal or decreased

Serum Ig levels
RA = normal
SLE = often increased

21
Q

what is c) Systemic sclerosis (scleroderma)

A

Systemic sclerosis (scleroderma)
• Systemic disease characterised by sclerosis of connective tissue.
• Often associated with other auto-immune diseases.
• Polyarthritis, induration of skin, Raynaud’s phenomenon.
• Involvement of blood vessels at other sites - gut wall, kidney, lung.

22
Q

what is Sjogren’s syndrome

A

Sjogren’s syndrome
• Clinical features: Dry mouth, dry eyes, and arthritis.
• Antibodies to extractable nuclear antigens (ENA): Ro and La; and Ig (Rheumatoid factor). • Destruction of salivary and lacrimal glands associated with lymphoid infiltration, germinal centre formation, sometimes progression to lymphoproliferative disorder.
• Association with other auto-immune diseases frequent.

23
Q

Include following core investigations in patients with suspected immune joint disease:

A

Acute phase reactant e.g. CRP and ESR Antibody e.g. ANA, ENA, RF Complement e.g. C3, C4
Immune complexes

24
Q

immunology of Sjogren’s Syndrome

A
  • Autoimmune inflammation of the salivary and lacrimal glands causes dry eyes and mouth.
  • High IgG levels lead to persistently very high ESR but normal CRP.
  • ANA, anti-Ro and anti-La are the most common autoantibodies
  • RF often positive but anti-CCP is not and they do not get erosive arthritis
25
Q

immunology of Systemic sclerosis (SSc)

A

Systemic Sclerosis (Scleroderma)
• ANA positive in 90% of cases
• Anti-dsDNA normal
• Anti-centromere suggests LIMITED SSc (sometimes called CREST syndrome)
• Anti-Scl70 suggests DIFFUSE SSc
• In the diffuse form more widespread areas of skin are involved
• Oesophageal dysmotility and dysphagia are common
• Watch out for breathlessness – could be pulmonary fibrosis or
pulmonary hypertension

26
Q

immunology of Seronegative inflammatory arthritis

A
  • Despite the negative antibodies, we can make a diagnosis of inflammatory arthritis on the symptoms and signs.
  • You could confirm this by ultrasound scan of the joints showing synovitis.
  • Prognosis is generally better than in seropositive disease.
  • Inflammatory markers are lower and Hb usually normal
  • Less likely to respond to B cell depletion with rituximab
27
Q

immunology of Seropositive rheumatoid arthritis

A
  • Not all patients with RA have positive autoantibodies
  • 70-80% have rheumatoid factor BUT healthy people can also have RF
  • In contrast fewer patients have anti-CCP but it rarely occurs in healthy people
  • The combination of RF +ve, anti-CCP +ve makes RA very likely
  • These seropositive patients have a worse outlook and need more aggressive treatment.
  • Inflammatory markers tend to be high and Hb may be low
28
Q

immunology of SLE

A
  • Classic symptoms (especially photosensitive facial rash)
  • Commonest in young women (esp Afro-Caribbean)
  • ANA positive in 95% but not specific
  • High anti-dsDNA and anti-Sm are specific
  • High ESR and normal CRP
  • Low Hb, WC and/or platelets are common
  • Complement depletion suggests active inflammation in the tissues.
29
Q

immunology of Drug –induced autoantibodies

A

• Anti-TNF drugs do induce ANA and anti-dsDNA in a minority of patients .
• Complement is not usually depleted because these antibodies are not causing tissue
inflammation
• In a drug reaction ESR and CRP are likely to go up together (not like SLE)
• If the drug is stopped the antibodies should disappear.
• In most cases patients don’t get ill. Drug-induced lupus is a condition with mild symptoms and anti-histone antibodies usually associated with other drugs (isoniazid, procainamide, minocycline) rather than anti-TNF.

30
Q

To make a diagnosis of Lupus the patient must have had at least FOUR of these 11 manifestations at any time since the onset of the disease.

A
  1. Malar rash fixed red rash over the cheeks
  2. Discoid rash red patches of skin associated with scaling and plugging of the hair follicles
  3. Photosensitivity rash after exposure to sunlight
  4. Mucosal ulcers small sores that occur in mucosal lining of mouth and nose
  5. Serositis inflammation of the delicate tissues covering internal organs and abdominal pain
  6. Arthritis -very common in lupus, pain in the joints
  7. Renal disorders usually detected by routine blood and urine analysis
  8. Neurological disorder seizures or psychosis
  9. Haematological disorder haemolytic anaemia, leukopenia, thrombocytopenia
  10. Immunologic disorder tests on LE cells, anti-DNA and anti-SM antibodies
  11. Anti-Nuclear Antibody (ANA blood test)
    when found in the blood and the patient is not taking drugs, it is known to cause a positive test for lupus in most cases, but is not necessarily conclusive
31
Q

Treatments for SLE:

A

Nonsteroidal anti-inflammatory drugs (NSAIDs)
Antimalarials, such as hydroxychloroquine
The mainstay of lupus treatment involves the use of anti-inflammatory corticosteroid hormones such as:
Prednisone
hydrocortisone
Methylprednisolone
Dexamethasone
Corticosteroids can be given by mouth, in creams applied to the skin, or by injection.
Immunosuppressives, such as azathioprine and cyclophosphamide, restrain the overactive immune system.
In some patients, methotrexate (chemotherapy) may be used to help control the disease.
Biological therapies